Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v13-EN | Version v4-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2025-01-03 | 2024-07-04 |
| Drug Identification Number | 02041472 | 02041472 |
| Brand name | ATIVAN | ATIVAN |
| Common or Proper name | Ativan 2mg Sublinguale | Ativan 2mg Sublinguale |
| Company Name | PFIZER CANADA ULC | PFIZER CANADA ULC |
| Ingredients | LORAZEPAM | LORAZEPAM |
| Strength(s) | 2MG | 2MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | SUBLINGUAL SUBLINGUAL | SUBLINGUAL SUBLINGUAL |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | Btl 1x100 | Btl 1x100 |
| ATC code | N05BA | N05BA |
| ATC description | ANXIOLYTICS | ANXIOLYTICS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-07-19 | |
| Actual start date | 2024-07-26 | |
| Estimated end date | Unknown | 2025-01-17 |
| Actual end date | ||
| Shortage status | Actual shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Sublingual presentation 1mg remains fully available | Stock is available, expiry date Jan/31/2025 |
| Health Canada comments |